首页 > 市场调查报告书 > 医疗设备

体外诊断生技设备

市场调查报告书

商品编码

1548095

全球组织诊断市场研究报告 - 2024 年至 2032 年行业分析、规模、份额、成长、趋势和预测

Global Tissue Diagnostics Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年07月01日 | 出版商:

Value Market Research | 英文 170 Pages | 商品交期: 最快1-2个工作天内

价格

简介目录图表

全球组织诊断市场需求预计将从 2023 年的 60.2 亿美元达到近 122.6 亿美元的市场规模，2024-2032 年研究期间复合年增长率为 8.22%。

组织诊断是癌症诊断和监测领域最先进的技术之一，也是市场成长的重要驱动力。基于组织的诊断技术能够找出患者疾病的原因和影响。由于人们的不健康习惯，癌症病例的盛行率逐年上升，从而推动了市场的成长。癌症初始阶段的诊断和治疗将带来更好的生存可能性，并且透过敦促实验室提高诊断程序的效率以最大限度地保护患者的健康，对诊断的需求将大幅增长。已开发国家比发展中国家有足够的健康意识，其中不同的因素是可信的，如健康素养低、经济因素和加强监管的必要性阻碍了市场的成长。

市场动态

组织是执行特定功能并包含重要生物讯息的一堆或一系列细胞。组织样本用于癌症诊断和监测，了解疾病的生物学背景。组织诊断的三个主要类别是免疫组织化学、苏木精和曙红以及原位杂交。苏木精和曙红染色与固定剂混合物配合使用效果更好，并显示出广泛的细胞质、细胞外基质和细胞核特征。免疫组织化学被认为是广泛使用的新诊断特征之一，其中蛋白质利用抗体染色，最后的原位杂交识别组织中的特定核苷酸系列。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具还对全球组织诊断市场的每个细分市场进行了包容性评估。组织诊断产业的成长和趋势为这项研究提供了整体方法。

市场区隔

组织诊断市场报告的这一部分提供了国家和区域层级细分市场的详细资料，从而帮助策略师确定相应产品或服务的目标人口统计数据以及即将到来的机会。

依技术

免疫组织化学（仪器（玻片染色系统、组织微阵列、组织处理系统、玻片扫描器、其他产品）、耗材（抗体、试剂、试剂盒））
原位杂交（仪器、耗材、软体）
初级和特殊染色
数位病理学和工作流程（全切片影像、影像分析资讯学、资讯管理系统储存和通讯）
解剖病理学（仪器（切片机和低温切片机、组织处理机、自动过滤器、其他产品）、消耗品（试剂和抗体、探针和试剂盒、其他）

按申请

乳癌
非小细胞肺癌
摄护腺癌
胃癌
其他癌症

按最终用途

医院
研究实验室
製药机构
合约研究组织 (CRO)

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲组织诊断市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。组织诊断市场的主要参与者包括罗氏有限公司、雅培实验室、赛默飞世尔科技公司、西门子、丹纳赫、BioMeRieux SA、Qiagen、BD、Merck KGaA、GE Healthcare、BioGenex、Cell Signaling Technology Inc. .、Bio SB、DiaGenic ASA、安捷伦科技。本节包含竞争格局的整体视图，包括各种策略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

依技术概述
历史和预测数据
技术分析
免疫组织化学（仪器（玻片染色系统、组织微阵列、组织处理系统、玻片扫描器、其他产品）、耗材（抗体、试剂、试剂盒））
原位杂交（仪器、耗材、软体）
初级和特殊染色
数位病理学和工作流程（全切片影像、影像分析资讯学、资讯管理系统储存和通讯）
解剖病理学（仪器（切片机和低温切片机、组织处理机、自动过滤器、其他产品）、消耗品（试剂和抗体、探针和试剂盒、其他）

第 6 章：全球组织诊断市场分析：依应用分类

概述：按应用
历史和预测数据
分析：按应用
乳癌
非小细胞肺癌
摄护腺癌
胃癌
其他癌症

第 7 章：全球组织诊断市场分析：依最终用途分类

按最终用途分类的概述
历史和预测数据
按最终用途分析
医院
研究实验室
製药机构
合约研究组织 (CRO)

第 8 章：全球组织诊断市场分析：依地理位置

区域展望
介绍
北美销售分析
- 概览、历史与预测资料销售分析
- 北美按细分市场销售分析
- 北美按国家销售分析
- 美国销售分析
- 加拿大销售分析
- 墨西哥销售分析
欧洲销售分析
- 概览、历史与预测资料销售分析
- 欧洲按细分市场销售分析
- 欧洲按国家销售分析
- 英国销售分析
- 法国销售分析
- 德国销售分析
- 义大利销售分析
- 俄罗斯销售分析
- 欧洲其他地区销售分析
亚太地区销售分析
- 概览、历史与预测资料销售分析
- 亚太地区按细分市场销售分析
- 亚太地区按国家销售分析
- 中国销售分析
- 印度销售分析
- 日本销售分析
- 韩国销售分析
- 澳洲销售分析
- 东南亚销售分析
- 亚太地区其他地区销售分析
拉丁美洲销售分析
- 概览、历史与预测资料销售分析
- 拉丁美洲按细分市场销售分析
- 拉丁美洲按国家销售分析
- 巴西销售分析
- 阿根廷销售分析
- 秘鲁销售分析
- 智利销售分析
- 拉丁美洲其他地区销售分析
中东和非洲销售分析
- 概览、历史与预测资料销售分析
- 中东和非洲按细分市场销售分析
- 中东和非洲按国家销售分析
- 沙乌地阿拉伯销售分析
- 阿联酋销售分析
- 以色列销售分析
- 南非销售分析
- 中东其他地区和非洲销售分析

第 9 章：组织诊断公司的竞争格局

组织诊断市场竞争
伙伴关係/协作/协议
併购
新产品发布
其他发展

第 10 章：公司简介

顶级公司市占率分析
市场集中度
F. Hoffmann-La Roche Ltd.

公司概况
公司收入
产品
最新动态

Abbott Laboratories

公司概况
公司收入
产品
最新动态

Thermo Fisher Scientific Inc.

公司概况
公司收入
产品
最新动态

Siemens

公司概况
公司收入
产品
最新动态

Danaher

公司概况
公司收入
产品
最新动态

BioMeRieux SA

公司概况
公司收入
产品
最新动态

Qiagen

公司概况
公司收入
产品
最新动态

公司概况
公司收入
产品
最新动态

Merck KGaA

公司概况
公司收入
产品
最新动态

GE Healthcare

公司概况
公司收入
产品
最新动态

BioGenex

公司概况
公司收入
产品
最新动态

Cell Signaling Technology Inc.

公司概况
公司收入
产品
最新动态

Bio SB

公司概况
公司收入
产品
最新动态

DiaGenic ASA

公司概况
公司收入
产品
最新动态

Agilent Technologies

公司概况
公司收入
产品
最新动态

註 - 在公司概况中，财务详细资讯和最新发展视情况而定，或对私人公司而言可能不包括在内

简介目录图表

Product Code: VMR11211672

The global demand for Tissue Diagnostics Market is presumed to reach the market size of nearly USD 12.26 Billion by 2032 from USD 6.02 Billion in 2023 with a CAGR of 8.22% under the study period 2024-2032.

Tissue Diagnostics is a technique which is one among the finest set in cancer diagnosis and monitoring and is the important driver in the market growth. Tissue based diagnosis technique enables to figure out the reason and impact of the disorder in a patient. Due to the unhealthy habits of people, the prevalence of cancer cases is rising over the years and so is propelling the growth of the market. Cancer diagnosis and treatment at initial stages will result in better possibilities of survival and the demand for diagnostics will register substantial growth by urging labs to improve efficiency in the diagnosis procedure to maximize health protection in sufferers. In developed countries there is adequate health consciousness than the developing countries for which different factors are credible as low health literacy, economic factors and enhancing regulatory necessities impede the market growth.

MARKET DYNAMICS

Tissue is a bunch or series of cells which execute a specific function and encompass essential biological information. Tissue specimens are used for cancer diagnosis and monitoring, where it apprehends the biological background of the disorder. The three main categories of tissue diagnosis are Immunohistochemistry, Hematoxylin and Eosin and In situ hybridization. Hematoxylin and Eosin tints work better with a mixture of fixatives and shows a wide range of cytoplasmic, extracellular matrix features and nuclear. Immunohistochemistry is known as the one among the vastly used new diagnostic traits where proteins are tinted utilizing antibodies and the last In-situ hybridization recognizes specific nucleotide series in the tissues.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Tissue Diagnostics. The growth and trends of Tissue Diagnostics industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Tissue Diagnostics market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Technology

Immunohistochemistry (Instruments (Slide Staining Systems, Tissue Microarrays, Tissue Processing Systems, Slide Scanners, Other Products), Consumables (Antibodies, Reagents, Kits))
In Situ Hybridization (Instruments, Consumables, Software)
Primary & Special Staining
Digital Pathology and Workflow (Whole Slide Imaging, Image Analysis Informatics, Information Management System Storage & Communication)
Anatomic Pathology (Instruments (Microtomes & Cryostat Microtomes, Tissue Processors, Automatic Strainers, Other Products), Consumables (Reagents & Antibodies, Probes & Kits, Others)

By Application

Breast Cancer
Non-small Cell Lung Cancer
Prostate Cancer
Gastric Cancer
Other Cancers

By End-use

Hospitals
Research Laboratories
Pharmaceutical Organizations
Contract Research Organizations (CROs)

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Tissue Diagnostics market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Tissue Diagnostics market include F. Hoffmann-La Roche Ltd., Abbott Laboratories, Thermo Fisher Scientific Inc., Siemens, Danaher, BioMeRieux SA, Qiagen, BD, Merck KGaA, GE Healthcare, BioGenex, Cell Signaling Technology Inc., Bio SB, DiaGenic ASA, Agilent Technologies. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. TISSUE DIAGNOSTICS - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Technology
- 3.7.2 Market Attractiveness Analysis By Application
- 3.7.3 Market Attractiveness Analysis By End-use
- 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL TISSUE DIAGNOSTICS MARKET ANALYSIS BY TECHNOLOGY

5.1. Overview By Technology
5.2. Historical and Forecast Data
5.3. Analysis By Technology
5.4. Immunohistochemistry (Instruments (Slide Staining Systems, Tissue Microarrays, Tissue Processing Systems, Slide Scanners, Other Products), Consumables (Antibodies, Reagents, Kits)) Historic and Forecast Sales By Regions
5.5. In Situ Hybridization (Instruments, Consumables, Software) Historic and Forecast Sales By Regions
5.6. Primary & Special Staining Historic and Forecast Sales By Regions
5.7. Digital Pathology and Workflow (Whole Slide Imaging, Image Analysis Informatics, Information Management System Storage & Communication) Historic and Forecast Sales By Regions
5.8. Anatomic Pathology (Instruments (Microtomes & Cryostat Microtomes, Tissue Processors, Automatic Strainers, Other Products), Consumables (Reagents & Antibodies, Probes & Kits, Others) Historic and Forecast Sales By Regions

6. GLOBAL TISSUE DIAGNOSTICS MARKET ANALYSIS BY APPLICATION

6.1. Overview By Application
6.2. Historical and Forecast Data
6.3. Analysis By Application
6.4. Breast Cancer Historic and Forecast Sales By Regions
6.5. Non-small Cell Lung Cancer Historic and Forecast Sales By Regions
6.6. Prostate Cancer Historic and Forecast Sales By Regions
6.7. Gastric Cancer Historic and Forecast Sales By Regions
6.8. Other Cancers Historic and Forecast Sales By Regions

7. GLOBAL TISSUE DIAGNOSTICS MARKET ANALYSIS BY END-USE

7.1. Overview By End-use
7.2. Historical and Forecast Data
7.3. Analysis By End-use
7.4. Hospitals Historic and Forecast Sales By Regions
7.5. Research Laboratories Historic and Forecast Sales By Regions
7.6. Pharmaceutical Organizations Historic and Forecast Sales By Regions
7.7. Contract Research Organizations (CROs) Historic and Forecast Sales By Regions

8. GLOBAL TISSUE DIAGNOSTICS MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1 Overview, Historic and Forecast Data Sales Analysis
- 8.3.2 North America By Segment Sales Analysis
- 8.3.3 North America By Country Sales Analysis
- 8.3.4 United States Sales Analysis
- 8.3.5 Canada Sales Analysis
- 8.3.6 Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1 Overview, Historic and Forecast Data Sales Analysis
- 8.4.2 Europe By Segment Sales Analysis
- 8.4.3 Europe By Country Sales Analysis
- 8.4.4 United Kingdom Sales Analysis
- 8.4.5 France Sales Analysis
- 8.4.6 Germany Sales Analysis
- 8.4.7 Italy Sales Analysis
- 8.4.8 Russia Sales Analysis
- 8.4.9 Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1 Overview, Historic and Forecast Data Sales Analysis
- 8.5.2 Asia Pacific By Segment Sales Analysis
- 8.5.3 Asia Pacific By Country Sales Analysis
- 8.5.4 China Sales Analysis
- 8.5.5 India Sales Analysis
- 8.5.6 Japan Sales Analysis
- 8.5.7 South Korea Sales Analysis
- 8.5.8 Australia Sales Analysis
- 8.5.9 South East Asia Sales Analysis
- 8.5.10 Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1 Overview, Historic and Forecast Data Sales Analysis
- 8.6.2 Latin America By Segment Sales Analysis
- 8.6.3 Latin America By Country Sales Analysis
- 8.6.4 Brazil Sales Analysis
- 8.6.5 Argentina Sales Analysis
- 8.6.6 Peru Sales Analysis
- 8.6.7 Chile Sales Analysis
- 8.6.8 Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1 Overview, Historic and Forecast Data Sales Analysis
- 8.7.2 Middle East & Africa By Segment Sales Analysis
- 8.7.3 Middle East & Africa By Country Sales Analysis
- 8.7.4 Saudi Arabia Sales Analysis
- 8.7.5 UAE Sales Analysis
- 8.7.6 Israel Sales Analysis
- 8.7.7 South Africa Sales Analysis
- 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE TISSUE DIAGNOSTICS COMPANIES

9.1. Tissue Diagnostics Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10. COMPANY PROFILES OF TISSUE DIAGNOSTICS INDUSTRY

10.1. Top Companies Market Share Analysis
10.2. Market Concentration Rate
10.3. F. Hoffmann-La Roche Ltd.
- 10.3.1 Company Overview
- 10.3.2 Company Revenue
- 10.3.3 Products
- 10.3.4 Recent Developments
10.4. Abbott Laboratories
- 10.4.1 Company Overview
- 10.4.2 Company Revenue
- 10.4.3 Products
- 10.4.4 Recent Developments
10.5. Thermo Fisher Scientific Inc.
- 10.5.1 Company Overview
- 10.5.2 Company Revenue
- 10.5.3 Products
- 10.5.4 Recent Developments
10.6. Siemens
- 10.6.1 Company Overview
- 10.6.2 Company Revenue
- 10.6.3 Products
- 10.6.4 Recent Developments
10.7. Danaher
- 10.7.1 Company Overview
- 10.7.2 Company Revenue
- 10.7.3 Products
- 10.7.4 Recent Developments
10.8. BioMeRieux SA
- 10.8.1 Company Overview
- 10.8.2 Company Revenue
- 10.8.3 Products
- 10.8.4 Recent Developments
10.9. Qiagen
- 10.9.1 Company Overview
- 10.9.2 Company Revenue
- 10.9.3 Products
- 10.9.4 Recent Developments
10.10. BD
- 10.10.1 Company Overview
- 10.10.2 Company Revenue
- 10.10.3 Products
- 10.10.4 Recent Developments
10.11. Merck KGaA
- 10.11.1 Company Overview
- 10.11.2 Company Revenue
- 10.11.3 Products
- 10.11.4 Recent Developments
10.12. GE Healthcare
- 10.12.1 Company Overview
- 10.12.2 Company Revenue
- 10.12.3 Products
- 10.12.4 Recent Developments
10.13. BioGenex
- 10.13.1 Company Overview
- 10.13.2 Company Revenue
- 10.13.3 Products
- 10.13.4 Recent Developments
10.14. Cell Signaling Technology Inc.
- 10.14.1 Company Overview
- 10.14.2 Company Revenue
- 10.14.3 Products
- 10.14.4 Recent Developments
10.15. Bio SB
- 10.15.1 Company Overview
- 10.15.2 Company Revenue
- 10.15.3 Products
- 10.15.4 Recent Developments
10.16. DiaGenic ASA
- 10.16.1 Company Overview
- 10.16.2 Company Revenue
- 10.16.3 Products
- 10.16.4 Recent Developments
10.17. Agilent Technologies
- 10.17.1 Company Overview
- 10.17.2 Company Revenue
- 10.17.3 Products
- 10.17.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

简介目录图表

LIST OF TABLES

Market Snapshot
Drivers: Impact Analysis
Restraints: Impact Analysis
List of Raw Material
List of Raw Material Manufactures
Analysis By Technology (USD MN)
Immunohistochemistry (Instruments (Slide Staining Systems, Tissue Microarrays, Tissue Processing Systems, Slide Scanners, Other Products), Consumables (Antibodies, Reagents, Kits)) Market Sales By Geography (USD MN)
In Situ Hybridization (Instruments, Consumables, Software) Market Sales By Geography (USD MN)
Primary & Special Staining Market Sales By Geography (USD MN)
Digital Pathology and Workflow (Whole Slide Imaging, Image Analysis Informatics, Information Management System Storage & Communication) Market Sales By Geography (USD MN)
Anatomic Pathology (Instruments (Microtomes & Cryostat Microtomes, Tissue Processors, Automatic Strainers, Other Products), Consumables (Reagents & Antibodies, Probes & Kits, Others) Market Sales By Geography (USD MN)
Analysis By Application (USD MN)
Breast Cancer Market Sales By Geography (USD MN)
Non-small Cell Lung Cancer Market Sales By Geography (USD MN)
Prostate Cancer Market Sales By Geography (USD MN)
Gastric Cancer Market Sales By Geography (USD MN)
Other Cancers Market Sales By Geography (USD MN)
Analysis By End-use (USD MN)
Hospitals Market Sales By Geography (USD MN)
Research Laboratories Market Sales By Geography (USD MN)
Pharmaceutical Organizations Market Sales By Geography (USD MN)
Contract Research Organizations (CROs) Market Sales By Geography (USD MN)
Global Tissue Diagnostics Market Sales By Geography (USD MN)
North America Market Analysis (USD MN)
United States Market Analysis (USD MN)
Canada Market Analysis (USD MN)
Mexico Market Analysis (USD MN)
Europe Market Analysis (USD MN)
Europe Market Estimate By Country (USD MN)
United Kingdom Market Analysis (USD MN)
France Market Analysis (USD MN)
Germany Market Analysis (USD MN)
Italy Market Analysis (USD MN)
Russia Market Analysis (USD MN)
Spain Market Analysis (USD MN)
Rest of Europe Market Analysis (USD MN)
Asia Pacific Market Analysis (USD MN)
China Market Analysis (USD MN)
Japan Market Analysis (USD MN)
India Market Analysis (USD MN)
South Korea Market Analysis (USD MN)
Australia Market Analysis (USD MN)
South East Asia Market Analysis (USD MN)
Rest of Asia Pacific Market Analysis (USD MN)
Latin America Market Analysis (USD MN)
Brazil Market Analysis (USD MN)
Argentina Market Analysis (USD MN)
Peru Market Analysis (USD MN)
Chile Market Analysis (USD MN)
Rest of Latin America Market Analysis (USD MN)
Middle East & Africa Market Analysis (USD MN)
Saudi Arabia Market Analysis (USD MN)
UAE Market Analysis (USD MN)
Israel Market Analysis (USD MN)
South Africa Market Analysis (USD MN)
Rest of Middle East and Africa Market Analysis (USD MN)
Partnership/Collaboration/Agreement
Mergers And Acquisition

LIST OF FIGURES

Research Scope of Tissue Diagnostics Report
Market Research Process
Market Research Methodology
Global Tissue Diagnostics Market Size, By Region (USD MN)
Porters Five Forces Analysis
Market Attractiveness Analysis By Technology
Market Attractiveness Analysis By Application
Market Attractiveness Analysis By End-use
Market Attractiveness Analysis By Region
Value Chain Analysis
Global Market Analysis By Technology (USD MN)
Immunohistochemistry (Instruments (Slide Staining Systems, Tissue Microarrays, Tissue Processing Systems, Slide Scanners, Other Products), Consumables (Antibodies, Reagents, Kits)) Market Sales By Geography (USD MN)
In Situ Hybridization (Instruments, Consumables, Software) Market Sales By Geography (USD MN)
Primary & Special Staining Market Sales By Geography (USD MN)
Digital Pathology and Workflow (Whole Slide Imaging, Image Analysis Informatics, Information Management System Storage & Communication) Market Sales By Geography (USD MN)
Anatomic Pathology (Instruments (Microtomes & Cryostat Microtomes, Tissue Processors, Automatic Strainers, Other Products), Consumables (Reagents & Antibodies, Probes & Kits, Others) Market Sales By Geography (USD MN)
Global Market Analysis By Application (USD MN)
Breast Cancer Market Sales By Geography (USD MN)
Non-small Cell Lung Cancer Market Sales By Geography (USD MN)
Prostate Cancer Market Sales By Geography (USD MN)
Gastric Cancer Market Sales By Geography (USD MN)
Other Cancers Market Sales By Geography (USD MN)
Global Market Analysis By End-use (USD MN)
Hospitals Market Sales By Geography (USD MN)
Research Laboratories Market Sales By Geography (USD MN)
Pharmaceutical Organizations Market Sales By Geography (USD MN)
Contract Research Organizations (CROs) Market Sales By Geography (USD MN)
Global Market Sales (USD MN)
North America Market Sales (USD MN)
Europe Market Sales (USD MN)
Asia Pacific Market Sales (USD MN)
Latin America Market Sales (USD MN)
Middle East & Africa Market Sales (USD MN)
Recent Development in Industry
Top Company Market Share Analysis